PRMT5 and hepatocellular carcinoma: For example, in the case of hepatocellular carcinoma, the phosphorylation/dephosphorylation of PRMT5 on T80 modulates its methyltransferase activity, and the dephosphorylating myosine phosphatase has a tumour suppressor role [9].